iVis Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

iVis Technologies is a long-established, privately-held Italian innovator in the ophthalmic medical device space. The company's core offering is the 4D Suite™, a closed-loop, wireless platform encompassing Diagnosis (Precisio® tomographer, pMetrics® pupillometer), Design (CIPTA®/CLAT software), Delivery (iRes® excimer laser), and Debriefing (iVerify® analytics). This integrated approach targets the growing market for personalized corneal surgery, including treatments for refractive error and ectatic diseases. Recent milestones include European Commission approval for its 4D Suite project under the IPCEI Tech4Cure program and the opening of a new headquarters, signaling growth and continued R&D investment.

Ophthalmology

Technology Platform

The 4D Suite™, an integrated wireless closed-loop platform for customized corneal surgery. It encompasses Diagnosis (Precisio® tomographer, pMetrics® pupillometer), Design (CIPTA®/CLAT surgical planning software), Delivery (iRes® excimer laser), and Debriefing (iVerify® outcome analytics software).

Opportunities

The growing global demand for personalized, high-precision vision correction surgery and advanced corneal therapeutic procedures presents a significant market opportunity.

Securing European Commission funding through the IPCEI Tech4Cure program validates the technology and provides non-dilutive capital for strategic R&D, potentially accelerating platform advancement and market penetration.

Risk Factors

Intense competition from large, established multinational medical device companies with greater resources and global reach poses a major challenge.

The company's integrated platform model requires full adoption by surgeons, creating a higher barrier to entry compared to selling individual point-solution devices.

Competitive Landscape

iVis competes in the ophthalmic surgical device market against giants like Alcon, Johnson & Johnson Vision, and Carl Zeiss Meditec. Its differentiation lies in its fully integrated, closed-loop platform for customized corneal surgery, a niche not fully addressed by the broader, more fragmented product portfolios of the major players.

More companies in Diagnostics & Precision Medicine →More companies in Italy →